Primary Care Providers' Intended Use of Decision Aids for Prostate-Specific Antigen Testing for Prostate Cancer Screening

Overview

Journal J Cancer Educ

Publisher Springer

Specialties Medical Education
Oncology

Date 2018 Mar 28

PMID 29582364

Citations 7

Authors

Sun Hee Rim

Ingrid J Hall

Greta M Massetti

Cheryll C Thomas

Jun Li

Lisa C Richardson

Affiliations

Soon will be listed here.

Abstract

Decision aids are tools intended to help people weigh the benefits and harms of a health decision. We examined primary care providers' perspective on use of decision aids and explored whether providers' beliefs and interest in use of a decision aid was associated with offering the prostate-specific antigen (PSA) test for early detection of prostate cancer. Data were obtained from 2016 DocStyles, an annual, web-based survey of U.S. healthcare professionals including primary care physicians (n = 1003) and nurse practitioners (n = 253). We found that the majority of primary care providers reported not using (patient) decision aids for prostate cancer screening, but were interested in learning about and incorporating these tools in their practice. Given the potential of decision aids to guide in informed decision-making, there is an opportunity for evaluating existing decision aids for prostate cancer screening for clinical use.

Citing Articles

Shared medical decision in prostate cancer screening in primary care: a systematic literature review of current evidence.

Lutaud R, Ollivier Q, Fierling T Int Urol Nephrol. 2024; 56(7):2251-2259.

PMID: 38316684 DOI: 10.1007/s11255-024-03947-4.

Shared decision-making before prostate cancer screening decisions.

Pekala K, Shill D, Austria M, Langford A, Loeb S, Carlsson S Nat Rev Urol. 2024; 21(6):329-338.

PMID: 38168921 PMC: 11250989. DOI: 10.1038/s41585-023-00840-0.

The effects of histone crotonylation and bromodomain protein 4 on prostate cancer cell lines.

Xu X, Zhu X, Liu F, Lu W, Wang Y, Yu J Transl Androl Urol. 2021; 10(2):900-914.

PMID: 33718091 PMC: 7947446. DOI: 10.21037/tau-21-53.

Understanding User Acceptance of Clinical Decision Support Systems to Promote Increased Cancer Screening Rates in a Primary Care Practice.

Kelsey E, Njeru J, Chaudhry R, Fischer K, Schroeder D, Croghan I J Prim Care Community Health. 2020; 11:2150132720958832.

PMID: 33016170 PMC: 7543103. DOI: 10.1177/2150132720958832.

Evaluating two decision aids for Australian men supporting informed decisions about prostate cancer screening: A randomised controlled trial.

Pickles K, Kazda L, Barratt A, McGeechan K, Hersch J, McCaffery K PLoS One. 2020; 15(1):e0227304.

PMID: 31940376 PMC: 6961909. DOI: 10.1371/journal.pone.0227304.

References

Herrmann A, Mansfield E, Hall A, Sanson-Fisher R, Zdenkowski N . Wilfully out of sight? A literature review on the effectiveness of cancer-related decision aids and implementation strategies. BMC Med Inform Decis Mak. 2016; 16:36. PMC: 4793751. DOI: 10.1186/s12911-016-0273-8. View

Taylor K, Williams R, Davis K, Luta G, Penek S, Barry S . Decision making in prostate cancer screening using decision aids vs usual care: a randomized clinical trial. JAMA Intern Med. 2013; 173(18):1704-12. PMC: 3992617. DOI: 10.1001/jamainternmed.2013.9253. View

Ilic D, Jammal W, Chiarelli P, Gardiner R, Hughes S, Stefanovic D . Assessing the effectiveness of decision aids for decision making in prostate cancer testing: a systematic review. Psychooncology. 2015; 24(10):1303-1315. DOI: 10.1002/pon.3815. View

Moyer V . Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012; 157(2):120-34. DOI: 10.7326/0003-4819-157-2-201207170-00459. View

Carter H, Albertsen P, Barry M, Etzioni R, Freedland S, Greene K . Early detection of prostate cancer: AUA Guideline. J Urol. 2013; 190(2):419-26. PMC: 4020420. DOI: 10.1016/j.juro.2013.04.119. View

Martinez-Gonzalez N, Djalali S, Tandjung R, Huber-Geismann F, Markun S, Wensing M . Substitution of physicians by nurses in primary care: a systematic review and meta-analysis. BMC Health Serv Res. 2014; 14:214. PMC: 4065389. DOI: 10.1186/1472-6963-14-214. View

Stamm A, Banerji J, Wolff E, Slee A, Akapame S, Dahl K . A decision aid versus shared decision making for prostate cancer screening: results of a randomized, controlled trial. Can J Urol. 2017; 24(4):8910-8917. View

Tasian G, Cooperberg M, Potter M, Cowan J, Greene K, Carroll P . PSA screening: determinants of primary-care physician practice patterns. Prostate Cancer Prostatic Dis. 2012; 15(2):189-94. DOI: 10.1038/pcan.2011.59. View

Graubard B, Korn E . Predictive margins with survey data. Biometrics. 2001; 55(2):652-9. DOI: 10.1111/j.0006-341x.1999.00652.x. View

10.

Bruen B, Ku L, Lu X, Shin P . No evidence that primary care physicians offer less care to Medicaid, community health center, or uninsured patients. Health Aff (Millwood). 2013; 32(9):1624-30. DOI: 10.1377/hlthaff.2012.1300. View

11.

Smith R, Manassaram-Baptiste D, Brooks D, Cokkinides V, Doroshenk M, Saslow D . Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2014; 64(1):30-51. DOI: 10.3322/caac.21212. View

12.

Stacey D, Legare F, Col N, Bennett C, Barry M, Eden K . Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014; (1):CD001431. DOI: 10.1002/14651858.CD001431.pub4. View

13.

Poghosyan L, Lucero R, Rauch L, Berkowitz B . Nurse practitioner workforce: a substantial supply of primary care providers. Nurs Econ. 2012; 30(5):268-74, 294. View

14.

Gutierrez J, Terwiesch C, Pelak M, Pettit A, Marcus S . Characterizing Primary Care Visit Activities at Veterans Health Administration Clinics. J Healthc Manag. 2015; 60(1):30-42. View

15.

Hall I, Rim S, Massetti G, Thomas C, Li J, Richardson L . Prostate-specific antigen screening: An update of physician beliefs and practices. Prev Med. 2017; 103:66-69. PMC: 5737769. DOI: 10.1016/j.ypmed.2017.08.004. View

16.

Carlsson S, Leapman M, Carroll P, Schroder F, Albertsen P, Ilic D . Who and when should we screen for prostate cancer? Interviews with key opinion leaders. BMC Med. 2015; 13:288. PMC: 4662021. DOI: 10.1186/s12916-015-0526-x. View

17.

Kim H, Benson D, Stern S, Gerber G . Practice trends in the management of prostate disease by family practice physicians and general internists: an internet-based survey. Urology. 2002; 59(2):266-71. DOI: 10.1016/s0090-4295(01)01504-7. View

18.

Wolf A, Wender R, Etzioni R, Thompson I, DAmico A, Volk R . American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010; 60(2):70-98. DOI: 10.3322/caac.20066. View

19.

Bornstein M, Ahmed F, Barrow R, Risley J, Simmons S, Workowski K . Factors Associated With Primary Care Physician Knowledge of the Recommended Regimen for Treating Gonorrhea. Sex Transm Dis. 2016; 44(1):13-16. DOI: 10.1097/OLQ.0000000000000542. View